Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114942) titled 'Immunotherapy Combined with Chemotherapy and then Maintenance Treatment in Advanced Stage Hypopharyngeal Cancer with Deferred Local Treatment: A Proof-of-Concept Phase II Clinical Study' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Hypopharyngeal cancer
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-12-25
Target Sample Size: Single-arm study:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...